Abbott Laboratories (ABT) shares are trading at a discount to the Zacks Medical Products industry. Its trailing 12-month price-to-book value of 4.91X is significantly lower than the industry average of 7.64X and the benchmark’s average of 8.77.The stock also remains attractively valued compared to its peers like Boston Scientific (BSX) with a P/B of 6.47X and Stryker (SYK) with a P/B of 6.72.A low P/B compared to the industry average and competitors can present a buying opportunity for value investors on th ...